The rapid rise of advanced biologics, including complex cell and gene therapies, has introduced unprecedented challenges to the pharmaceutical supply chain. Because these high-value therapeutics often require storage at extreme sub-zero and cryogenic temperatures, their packaging systems are subjected to severe physical stress. When exposed to deep freeze environments, the elastomeric closures, rubber stoppers, and glass or polymeric components of a vial contract at entirely different rates. This thermal expansion mismatch frequently causes the seals to temporarily fail, creating temporary micro-leaks that disappear once the package warms back up to room temperature. Traditional room-temperature testing methods completely miss these cold-chain defects, creating a dangerous gap in quality assurance. This blog post addresses this specific vulnerability by detailing how helium leak testing can be successfully conducted at ultra-low storage conditions. Utilizing specialized low-temperature add-on units like the LT80 and LT150, manufacturers can perform concurrent temperature conditioning, real-time temperature monitoring, and ultra-sensitive helium leak testing down to -80°C or even -150°C. This allows quality teams to evaluate fine leakage under realistic storage and transport conditions, verifying container closure integrity when the package is at its most vulnerable. By identifying hidden seal weaknesses caused by cryogenic stress, companies can optimize their cold chain packaging designs, minimize product failure during distribution, and ensure compliance with stringent USP <1207> guidelines. Read the complete article to understand how sub-zero helium leak detection can protect your temperature-sensitive biologics from contamination and secure the therapeutic integrity of advanced medicines throughout their entire shelf life.
